— Know what they know.
Not Investment Advice
Also trades as: KTTA (NASDAQ) · $vol 0M

KTTAW NASDAQ

Pasithea Therapeutics Corp.
1W: +3.7% 1M: -60.6% 3M: -62.7% YTD: -80.7% 1Y: -88.8%
$0.00
-0.00 (-6.67%)
 
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $20838 mcap · 7M float · 0.156% daily turnover · Short 52% of daily vol

Supply Chain Overview

15 relationships
15
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-06-22
Earliest Filing
2024-11-26
Latest Filing
partner: 11 target: 4

Counterparties (Filed by KTTAW)

15 relationships

Companies named in KTTAW's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
H.C. Wainwright & Co., LLC — partner Sales Agent for the At The Market Offering Agreement 2024-11-26 View
Concord IP2 Ltd. — partner Plaintiff in litigation and party to settlement agreement 2022-12-14 View
Elderhill Corporation — partner Plaintiff in litigation and party to settlement agreement 2022-12-14 View
Leonite Capital LLC — partner Plaintiff in litigation and party to settlement agreement 2022-12-14 View
Leonite Fund I, LP — partner Plaintiff in litigation and party to settlement agreement 2022-12-14 View
Camac Partners, LLC — partner Member of Camac Group and party to settlement agreement 2022-12-14 View
Camac Capital, LLC — partner Member of Camac Group and party to settlement agreement 2022-12-14 View
Camac Fund, LP — partner Member of Camac Group and party to settlement agreement 2022-12-14 View
David Delaney — partner Individual member of Camac Group 2022-12-14 View
Avi Geller — partner Individual member of Camac Group 2022-12-14 View
Eric Shahinian — partner Individual member of Camac Group 2022-12-14 View
AlloMek Therapeutics, LLC — target Target company whose 100% equity was acquired by Pasithea Therapeutics Corp. 2022-10-12 View
PD Joint Holdings, LLC Series 2016-A — target Seller of Alpha-5 integrin, LLC equity in exchange for stock, warrants, and contingent earn-outs 2022-06-22 View
Lawrence Steinman — target Seller of Alpha-5 integrin, LLC equity in exchange for stock, warrants, and contingent earn-outs 2022-06-22 View
Alpha-5 integrin, LLC — target Delaware limited liability company whose equity was acquired by Pasithea Therapeutics Corp. 2022-06-22 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-16 Other Events View
2026-09-09 Shareholder Vote; Exhibits View
2026-05-04 Officer/Director Change; Regulation FD; Exhibits View
2026-02-20 Notice of Delisting or Transfer View
2026-01-28 Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or View
2025-12-15 Other Events View
2025-12-02 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis Agreement View
2025-11-25 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-11-04 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-10-27 Departure/Election of Directors; Appointment of Officers View
2025-09-16 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-09-03 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-07-11 Shareholder Nominations View
2025-06-27 Notice of Delisting or Transfer View
2025-06-20 Other Events; Financial Statements and Exhibits View
2025-05-07 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-04-25 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2024-11-26 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2024-09-30 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2024-06-26 Submission of Matters to a Vote of Security Holders View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms